ARTICLE | Company News
GeneMedicine other research news
August 9, 1993 7:00 AM UTC
GeneMedicine received a Phase I $50,000 SBIR grant from the National Institute of Arthritis, Muscoloskeletal and Skin Disorders for the development of gene medicines for inflammatory and infectious sk...